Consultation display

Gynaecological cancers

Response to the consultation

Evidence submitted in response to this Consultation

Purpose of the consultation

Purpose of the consultation

Gynaecological cancers include womb (uterus), ovarian, cervical, vulval and vaginal cancers. In July 2022, only 34 per cent of gynaecological cancers met the Single Cancer Pathway target.

 

The Health and Social Care Committee is looking at the experiences of women with symptoms of gynaecological cancer, how they are listened to and treated by healthcare professionals, and how services empower, care for and look after women diagnosed with a gynaecological cancer (to ensure their physical, psychological and practical needs are met).

 

In particular, the Committee is considering:

>>>> 

>>>The information available and awareness about the risk factors for gynaecological cancers across the life course and the symptoms associated with gynaecological cancers.

>>>The barriers to securing a diagnosis, such as symptoms being dismissed or confused with other conditions.

>>>Whether women feel they are being listened to by healthcare professionals and their symptoms taken seriously.

>>>HPV vaccination and access to timely screening services including consideration of the inequalities and barriers that exist in uptake among different groups of women and girls.

>>>NHS recovery of screening and diagnostic services, specifically the level of extra capacity that has been provided for services to recover from the impact of the COVID-19 pandemic.

>>>The prioritisation of pathways for gynaecological cancers as part of NHS recovery, including how gynaecological cancer waiting lists compare to other cancers and other specialities.

>>>Whether there are local disparities in gynaecological cancer backlogs (addressing inequalities so that access to gynaecological cancer care and treatment is not dependent on where women live).

>>>The extent to which data is disaggregated by cancer type (as opposed to pooling all gynaecological cancers together) and by other characteristics such as ethnicity.

>>>Whether adequate priority is given to gynaecological cancers in the forthcoming Welsh Government/NHS Wales action plans on women and girls’ health and cancer, including details of who is responsible for the leadership and innovation needed to improve cancer survival rates for women.

>>>The extent to which gynaecological cancers, and their causes and treatments (including side-effects), are under-researched; and the action needed to speed up health research and medical breakthroughs in diagnosing and treating gynaecological cancers.

>>>The priority given to planning for new innovations (therapy, drugs, tests) that can improve outcomes and survival rates for women.

<<< 

 

Evidence gathering

We want to make sure that our work is informed by experiences, needs, and views that reflect the diversity of the people and communities affected by these issues.

 

We encourage anyone with expertise or experience of these issues to share your views, with the full knowledge that your views will be welcomed and valued.

 

Due to the Committee’s forthcoming work on the Health Service Procurement (Wales) Bill, the deadline for submitting evidence to this inquiry has been extended to Friday 17 March.

 

Along with your submission, you should provide the following information:

>>>> 

>>>Your name and contact details as the person, or organisation, submitting the evidence.

>>>Whether your evidence is submitted as an individual, or on behalf of an organisation.

>>>If you are submitting evidence as an individual, confirmation that you are over 18 years old.

>>>If you are under 13 years old, your parent or guardian’s agreement that you can participate (this can be provided via email).

>>>Confirmation of whether you would prefer that your name is not published alongside your evidence (names of individuals under 18 years old will not be published).

>>>Confirmation of whether you would like the committee to treat any or all of your written evidence as confidential, with reasons for the request.

>>>If you have referred to a third party in your evidence, such as a parent, spouse or relative, confirmation that they have agreed that you can share information that may be used to identify them and that they understand that it will be published.

<<< 

 

How to share your views

To share your views electronically, please send to SeneddHealth@senedd.wales, or by post to Health and Social Care Committee, Welsh Parliament, Cardiff, CF99 1SN.

 

 

Providing Written Evidence

The Senedd has two official languages, Welsh and English.

 

In line with the Senedd’s Official Languages Scheme the Committee requests that documents or written responses to consultations intended for publication or use in Senedd proceedings are submitted bilingually. When documents or written responses are not submitted bilingually, we will publish in the language submitted, stating that it has been received in that language only.

 

We expect other organisations to implement their own standards or schemes and to comply with their statutory obligation.

 

Please see guidance for those providing evidence for committees.

 

Disclosure of information

Please ensure that you have considered the Senedd’s policy on disclosure of information before submitting information to the Committee.

Contact details

Should you wish to speak to someone regarding this consultation, please use the below contact details:

Health and Social Care Committee
Welsh Parliament
Cardiff Bay
Cardiff
CF99 1SN

Email: SeneddHealth@senedd.wales
Telephone: 0300 200 6565